Review of Newer Anticoagulants and Anti-platelet Agents in Acute Coronary Syndrome and Cardiovascular Diseases

ISSN: 1875-6182 (Online)
ISSN: 1871-5257 (Print)

Volume 13, 2 Issues, 2015

Download PDF Flyer

Cardiovascular & Hematological Agents in Medicinal Chemistry

Formerly: Current Medicinal Chemistry - Cardiovascular & Hematological Agents

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Debabrata Mukherjee
Department of Internal Medicine Texas Tech University
4800 Alberta Avenue El Paso
Texas, 79905

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Review of Newer Anticoagulants and Anti-platelet Agents in Acute Coronary Syndrome and Cardiovascular Diseases

Author(s): Sucheta Gosavi and Debabrata Mukherjee

Affiliation: Department of Internal Medicine, Texas Tech University Health Sciences Center, Paul L Foster School of Medicine, 4800, Alberta Avenue Suite 123, El Paso, TX 79905, USA.


In the last few years three new oral anticoagulants-Dabigatran, Rivaroxaban and Apixaban and two new antiplatelet agents Prasugrel and Ticagrelor have been approved for use. Dabigatran, Rivaroxaban and Apixaban have been approved for the prevention of stroke and systemic embolism in non valvular Atrial Fibrillation in the United States. Rivaroxaban is also approved for the prevention and treatment of venous thromboembolism, including pulmonary embolism. These drugs have been shown to be non-inferior to Warfarin. These drugs do not need monitoring and have lesser drug interactions compared to Warfarin. The newer antiplatelet agents Prasugrel and Ticagrelor are more potent than Clopidogrel and are more effective in patients with CYP2 C19 enzyme deficiency. Both of these drugs are approved in acute coronary syndrome and Prasugrel is approved only in acute coronary syndrome with percutaneous coronary intervention.

Keywords: Apixaban, cardiovascular diseases, Dabigatran, newer antiplatelet agents, newer oral anticoagulants, Prasugrel, Rivaroxaban, thromboembolism, Ticagrelor.

Purchase Online Order Reprints Order Eprints Rights and Permissions


Article Details

Volume: 11
Issue Number: 3
First Page: 194
Last Page: 202
Page Count: 9
DOI: 10.2174/18715257113119990084

Related Journals

Webmaster Contact: Copyright © 2015 Bentham Science